Case Western, ICBM Med­i­cal part­ner to de­velop pa­tient screen­ing tech­nol­ogy

Modern Healthcare - - REGIONAL NEWS - —Ly­dia Coutré, Crain’s Cleve­land Busi­ness

Case Western Re­serve Univer­sity and Cleve­land-based ICBM Med­i­cal signed a li­cense agree­ment to fur­ther de­velop tech­nol­ogy to pro­vide pa­tient screen­ing and mon­i­tor­ing for a range of crit­i­cal clin­i­cal con­di­tions in­clud­ing prostate can­cer and con­cus­sions.

Li­cens­ing for the low-cost, rapid screen­ing and mon­i­tor­ing was is­sued through Case Western’s Tech­nol­ogy Trans­fer Of­fice. Last fall, the two signed a one-year op­tion-to-li­cense agree­ment for the tech­nol­ogy, ac­cord­ing to a news re­lease. The next steps will be op­ti­miz­ing de­signs, pro­duc­ing pro­to­types and be­gin­ning clin­i­cal test­ing in 2018. ICBM Med­i­cal so far has re­ceived “suf­fi­cient fund­ing” to carry it through these steps as it moves to­ward se­cur­ing a Se­ries A pre­ferred in­vest­ment, ac­cord­ing to the news re­lease.

“The com­ple­tion of the CWRU-ICBM Med­i­cal li­cense agree­ment en­ables us to con­fi­dently ramp up the near-term prod­uct devel­op­ment ac­tiv­i­ties,” ICBM Med­i­cal CEO Stephanie Har­ring­ton said in a state­ment.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.